MYND Life Sciences Inc.

OTCPK:MYND.F Stock Report

Market Cap: US$3.1m

MYND Life Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jay Campbell

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.1yrs
CEO ownershipn/a
Management average tenure3yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

CEO

Jay Campbell (53 yo)

1.1yrs

Tenure

Mr. John Campbell, ICD D., also known as Jay, served as an Independent Director of GOLO Mobile Inc. since January 2022 until May 2024. He served as Director of Gegs Capital Corp since April 25, 2018.Mr. C...

Leadership Team

NamePositionTenureCompensationOwnership
Wilfred Jefferies
Co-Founder & Chief Science Officer4.2yrsCA$240.00kno data
Lih-Ming Tam
CFO & Senior Controller2.9yrsCA$82.08kno data
Lyle Oberg
Co-Founder & Executive Chairman of the Board4.2yrsno datano data
John Campbell
President1.1yrsno datano data
Chaahat Singh
Senior Operations & Research Manager3yrsno datano data
Luke Warkentin
Vice President of Corporate Development3yrsno datano data
Iryna Saranchova
Chief Clinical Officerno datano datano data

3.0yrs

Average Tenure

64yo

Average Age

Experienced Management: MYND.F's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lyle Oberg
Co-Founder & Executive Chairman of the Board4.2yrsno datano data
John Campbell
President4.2yrsno datano data
Mark Geyer
Member of Scientific Advisory Board3.7yrsno datano data
Michael Brownstein
Member of Scientific Advisory Board3.7yrsno datano data
Roslyn Ritchie-Derrien
Independent Director4.2yrsno datano data
John Trowsdale
Member of Scientific Advisory Board3.7yrsno datano data
Scott Nicoll
Independent Director3.3yrsno datano data
Laurie Bakke
Independent Non Executive Directorless than a yearno datano data
Lana Hoogenboom
Directorless than a yearno datano data

3.7yrs

Average Tenure

61yo

Average Age

Experienced Board: MYND.F's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 21:56
End of Day Share Price 2025/01/03 00:00
Earnings2024/07/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MYND Life Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution